Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

Abstract excerpt

Recurrent cytogenetic abnormalities have provided the backbone for prognosticating acute myeloid leukemia and predicting response to consolidative therapies for decades. However, more than 45% of acute myeloid leukemia patients have normal cytogenetics on both karyotype and fluorescence in situ hybridization at diagnosis. Increasingly utilized next-generation sequencing has led to the discovery of numerous...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Disease
• Share to Genetic Predisposition to Disease
• Share to Leukemia, Myeloid